(Q43237259)

17 November 2017

0 references

An antidote for calcium leak: targeting molecular arrhythmia mechanisms (English)

1 reference

17 November 2017

Stephan E Lehnart

1

1 reference

PubMed ID

19931542

17 November 2017

W J Lederer

series ordinal

2

1 reference

17 November 2017

26 November 2009

1 reference

Journal of Molecular and Cellular Cardiology

17 November 2017

1 reference

17 November 2017

48

1 reference

17 November 2017

279-282

1 reference

17 November 2017

2

1 reference

Cellular origins of the transient inward current in cardiac myocytes. Role of fluctuations and waves of elevated intracellular calcium

17 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

Inotropic and arrhythmogenic effects of potassium-depleted solutions on mammalian cardiac muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

Role of calcium ions in transient inward currents and aftercontractions induced by strophanthidin in cardiac Purkinje fibres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

Transient inward current underlying arrhythmogenic effects of cardiotonic steroids in Purkinje fibres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

Cellular and subcellular heterogeneity of [Ca2+]i in single heart cells revealed by fura-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

Effect of Calcium on Acetylstrophanthidin-Induced Transient Depolarizations in Canine Purkinje Tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

Regulation of ryanodine receptors in the heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

Sarcoplasmic reticulum Ca2+ and heart failure: roles of diastolic leak and Ca2+ transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

Interactions of flecainide with guinea pig cardiac sodium channels. Importance of activation unblocking to the voltage dependence of recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

The effect of tetracaine on spontaneous Ca2+ release and sarcoplasmic reticulum calcium content in rat ventricular myocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

The effects of low concentrations of caffeine on spontaneous Ca release in isolated rat ventricular myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

Reducing ryanodine receptor open probability as a means to abolish spontaneous Ca2+ release and increase Ca2+ transient amplitude in adult ventricular myocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

An anionic ryanoid, 10-O-succinoylryanodol, provides insights into the mechanisms governing the interaction of ryanoids and the subsequent altered function of ryanodine-receptor channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

Common molecular determinants of flecainide and lidocaine block of heart Na+ channels: evidence from experiments with neutral and quaternary flecainide analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

Novel targets for treating heart and muscle disease: stabilizing ryanodine receptors and preventing intracellular calcium leak

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

Effects of a novel cardioprotective drug, JTV-519, on membrane currents of guinea pig ventricular myocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.11.005

10.1016/J.YJMCC.2009.11.005

7 January 2021

Identifiers

DOI

1 reference

17 November 2017

1 reference

PubMed ID

19931542